Dissemin is shutting down on January 1st, 2025

Published in

Taylor and Francis Group, OncoImmunology, 7(8), p. e1599636, 2019

DOI: 10.1080/2162402x.2019.1599636

Links

Tools

Export citation

Search in Google Scholar

Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells

Journal article published in 2019 by Maria C. Ochoa, Elisabeth Perez-Ruiz, Luna Minute, Carmen Oñate, Guiomar Perez, Inmaculada Rodriguez, Aintzane Zabaleta, Diego Alignani, Myriam Fernandez-Sendin, Ascension Lopez, Aura Muntasell, Miguel F. Sanmamed, Bruno Paiva ORCID, Miguel Lopez-Botet, Pedro Berraondo ORCID and other authors.
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO